Within the global CD45+ immune cell population, CCR7+ population correlated with smaller prostate tumor volume (PTV) (r = − 0.507, p = 0.026) and less extra-prostatic extension (EPE) (r = − 0.517, p = 0.023) (Supplementary Table S3). Here, CCR7 is linked to prostate neoplasm.